Group items tagged

Apixaban is a new prescription drug that is being introduced into the market to treat patients who have an atrial flutter. It is being designed as an angiotensin Iodine C injection drug. Apixaban works by blocking the effects of the angiotensin II enzyme in the blood. The medication has been shown to improve symptoms of atrial flutter in patients who have been prescribed it. Moreover, smoking is prohibited while using this medicine

Antidiabetic Biosimilars have become one of the most common solutions to the diabetes problem, providing significant advances in medical science and technology for the better treatment of Diabetes Type I and II patients.

Pompe disease or additionally alluded to as Glycogen stockpiling sickness type II is an autosomal passive metabolic problem that harms nerve cells and muscles all through the body. It is normally caused because of the aggregation of glycogen in the lysosome, inferable from insufficiency of the lysosomal corrosive alpha-glucosidase chemical.

Pompe disease or also referred to as Glycogen storage disease type II is an autosomal recessive metabolic disorder that damages nerve cells and muscles throughout the body.

Antidiabetic Biosimilars have become one of the most common solutions to the diabetes problem, providing significant advances in medical science and technology for the better treatment of Diabetes Type I and II patients.

Accessibility of better treatment choices for hypertension has lead considerable bit of the hypertensive populace with controlled circulatory strain. Yet, rising populace with cardiovascular, and related problems urges need for various antihypertensive medications in the worldwide market.